*Note: For the investigational use of Adipose Derived Stem Cells (ADSC’s) for clinical research and deployment.
Autoimmune disorders occur when the body fails to tell the difference between self and non-self. When this happens, the body makes antibodies that are directed towards the body’s own tissues. These are called auto-antibodies. The autoantibodies attack the normal, healthy cells by mistake.
Autoimmune diseases can affect various organs and organ systems. The immune system activity causes inflammation of affected tissue, which can lead to damage that affects normal function. In the United States at least 23.5 million are affected by an autoimmune disorder. These disorders are one of the leading causes of death and disability.
Traditional treatment methods focus on reducing normal immune system activity, often impacting other aspects of overall health and mobility. The use of steroid based medications and therapies is common for many autoimmune diseases, but these necessary treatments can have side effects that damage healthy tissue and affect physical health in the long run.
Dr. Todd Malan offers stem cell therapy for patients with a range of autoimmune disorders that has been effective in restoring the health and function of damaged tissue for both improved overall health and disease management.
At The Center For Regerative Cell Medicine we are currently studying and offering treatment for the following disorders:
Why Choose Us?
The Center for Regenerative Cell Medicine is home to an experienced team of medical professionals led by Dr. Todd Malan, one of the key physicians in the United States when it comes to stem cell treatments and therapies for a wide range of conditions and diseases.
Dr. Malan offers consultative, compassionate treatment for autoimmune disease using stem cells to address the tissue damage and inflammation that makes many conditions painful and difficult to manage. A pioneer in the study, development and implementation of stem cell therapies, Dr. Malan understands the science behind each treatment and has continued to develop targeted treatment options for specific diseases.